| abstract |
The invention relates to fully human antibodies, and fragments thereof, that bind to human interferon gamma (hlFN.gamma.), thereby modulating the interaction between IFN.gamma. and its receptor, IFN.gamma.-R, and/or modulating the biological activities of IFN.gamma.. The invention also relates to the use of such anti-IFN.gamma. antibodies in the prevention or treatment of immune- related disorders and in the amelioration of a symptom associated with an immune-related disorder. |